Biopharmaceutical industry exceeded our wildest expectations

Less than a year after the pandemic began, Americans had access to three highly effective vaccines that are paving the way forward and away from COVID-19, and that number could soon rise, as the FDA considers promising candidates from AstraZeneca and Novavax.


Click to read the full article @The Baltimore Times